Event Panel Schedule


TBA
Re­cap of 2020 & The dif­fer­ent IPO mod­els – What have we learned? What worked? What is here to stay? What do we miss the most?
Webcast
Da64898bf27b3860bffa517c749e88ac_3cd99ca458c0535701c9eff873f4d9f2_120_120
Oppenheimer & Co. Inc.
Stefan Loren, Ph.D., Managing Director / Oppenheimer & Co. Inc.
Loren is a managing director at Oppenheimer & Co.. Prior to joining Oppenheimer Loren was managing partner at Leap Day Capital (2014-2017) and board director for GenVec (2013-2017). Loren graduated with a PhD. in Organic/Pharmaceutical…

4d035864628b3dff1d266b29266e8d74_aea1c56ce44d424b8f0c259b92e14af6_120_120
Oppenheimer & Co. Inc.
Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking / Oppenheimer & Co. Inc.
Mr. Michael Margolis serves as Co-Head of Healthcare Investment Banking at Oppenheimer & Company. He served as a Managing Director, Healthcare Investment Banking at Roth Capital Partners. He was most recently a Managing Director of Healthcare…

Ee75229abc901efffb074566ebcae462_dd9d1bab16506ecebd6007ce882e06aa_120_120
Alpha Healthcare Acquisition
Rajiv Shukla, Chairman & CEO / Alpha Healthcare Acquisition
Alpha Healthcare Acquisition Corp is led by Chairman and CEO, Rajiv Shukla. Rajiv is a long-time healthcare investor and 3-time public company CEO. His previous SPAC acquired DermTech, a disruptive non-invasive cancer diagnostic company. DMTK stock…

6b9f30d055c539dfd3ecb726108c6fb9_d03c03bcee196577de3524e00b920e4f_120_120
Larimar Therapeutics
Michael Celano, CFO / Larimar Therapeutics
Michael Celano joined Larimar Therapeutics in June 2020, as Chief Financial Officer (CFO). He brings over 30 years’ experience as a life science business leader with a broad skill set including capital raising, creative financing structures, investor…

D4f9ee0c37a58033818ea1f47baf3d49_e8a0ba9f9a89e278fe86bdc89d08c76b_120_120
Solebury Trout
Jennifer Porcelli, Managing Director / Solebury Trout
Jen Porcelli is a Managing Director in the New York office. Jen works with a broad spectrum of privately-held and publicly-traded life sciences companies throughout various stages of the funding lifecycle; she provides management teams with…

17028b016c5979705dfd095d9f846e85_90c3cb7019e196d1dbc4e3d5699d45f2_120_120
White & Case LLP
Joel Rubinstein, Partner / White & Case LLP
Joel Rubinstein is a partner at White & Case, and a member of the Firm’s Capital Markets Practice. Joel has broad experience in corporate and securities matters, representing clients in public offerings and private placements of securities…

Bef3bc9fa26fa57503c073ca5112e334_45e3516031162d107dc98ffa51d9835d_120_120
White & Case LLP
Stuart Bressman, Partner / White & Case LLP
Stuart advises investment banks and issuers on public and private securities offerings by US and non-US companies. Clients also seek him out for his market-leading experience in alternative financing techniques, such as confidentially marketed public…
Export to Excel